What is the minimum investment required for PCD Pharma Franchise?

The minimum investment typically ranges from ₹2–5 lakhs, depending on territory size, product selection and initial stock planning. Our team will help structure this based on your goals.

What documents are required to become a franchise partner?

You will need a valid Drug License, GST registration and basic KYC documents. Our team will guide you through every step of the documentation process.

What kind of support and training do you provide?

We provide product training, sales guidance, marketing materials, doctor coverage strategies, and ongoing business support through dedicated account managers.

How are territories allocated and protected?

Territories are allocated based on mutual agreement and market mapping. We offer genuine monopoly rights with clear documentation to avoid internal competition.

What is the expected profit margin and ROI timeline?

Average profit margins range from 25–30%, with typical ROI timelines between 12–18 months, depending on your execution and territory potential.

How do you ensure product quality and compliance?

All products are manufactured in WHO-GMP certified facilities with 100% quality testing, robust documentation and DCGI approvals as applicable.

What is the delivery timeline and process?

Dispatch timelines depend on order size and location, but we maintain a strong track record of timely delivery across India with proper packaging and logistics partners.

Antibiotics/Anti-infectives

STECIX LB

Cefixime 50mg + Lactic Acid Bacillus 60 Million Spores

Pack: 30ML
Format: With Carton

MRP₹75.00

A dual-action antibacterial and probiotic formula designed to treat pediatric infections while protecting the delicate balance of the gut microbiome. STECIX LB combines a third-generation cephalosporin with Lactic Acid Bacillus to prevent antibiotic-associated diarrhea and ensure a comfortable recovery.

About The Product

Key Benefits

Advanced Third-Generation Antibacterial Action

Cefixime 50mg is a potent third-generation cephalosporin that works by inhibiting bacterial cell wall synthesis. It is highly effective against a broad spectrum of Gram-positive and Gram-negative pathogens, offering superior clinical outcomes in treating pediatric infections that may be resistant to older penicillins.

Probiotic Gut Protection

Antibiotics can often disrupt the natural "good" bacteria in the digestive tract, leading to stomach upset and diarrhea. The inclusion of Lactic Acid Bacillus (60 Million Spores) helps replenish the gut flora during the course of treatment, maintaining a healthy microbial balance and improving overall digestion.

Prevention of Antibiotic-Associated Diarrhea (AAD)

Lactic Acid Bacillus is a resilient probiotic that survives stomach acid to reach the intestines. By restoring the intestinal environment, it significantly reduces the incidence of diarrhea and abdominal cramping, which are common side effects of antibiotic therapy in children.

Targeteddd Management of Enteric and Respiratory Infections

STECIX LB is a gold-standard choice for treating typhoid fever, acute otitis media (middle ear infection), and tonsillitis. Its excellent tissue penetration ensures that the antibiotic reaches the site of infection rapidly while the probiotic component safeguards the child's digestive health.

High Stability Against Bacterial Enzymes

Cefixime remains exceptionally stable in the presence of beta-lactamase enzymes produced by resistant bacteria. This ensures that STECIX LB remains active and potent where other medications might fail, providing a reliable defense against tough pediatric pathogens.

Enhanced Patient Compliance and Comfort

By addressing both the infection and the potential gastrointestinal side effects in a single formulation, STECIX LB improves patient compliance. Children experience fewer stomach-related complications, leading to a smoother and faster recovery process for the young patient.

Indication Typhoid (Enteric) Fever, Acute Otitis Media, Tonsillitis and Pharyngitis, Urinary Tract Infections (UTIs), Respiratory Tract Infections, Prevention of Antibiotic-Induced Diarrhea.

Indications

Typhoid (Enteric) Fever
Acute Otitis Media
Tonsillitis and Pharyngitis
Urinary Tract Infections (UTIs)
Respiratory Tract Infections
Prevention of Antibiotic-Induced Diarrhea.

Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.

STECIX LB